Hologic sells Lifecodes to Immucor for $85M

January 4, 2013 by MassDevice staff

Immucor agrees to acquire Hologic's Lifecodes transplant diagnostics business in a deal worth up to $95 million, marking the 1st publicly reported acquisition by Immucor since former Medtronic CEO William Hawkins took the corner office.

M&A illustration

In-vitro diagnostics maker Immucor (NSDQ:BLUD) signed a definitive agreement to acquire the Lifecodes transplant diagnostics business of Hologic (NSDQ:HOLX) in a deal worth up to $95 million.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.